Back
Black Diamond Therapeutics Stock Price Chart
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Sell
34
BDTX
Black Diamond Therapeutics
Last Price:
2.87
Seasonality Move:
21.63%
7 Day Trial
ALL ACCESS PASS
$
7
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDTX is experiencing selling pressure, which indicates risk of future bearish movement.
Black Diamond Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.22 | Sell |
| 20-day SMA: | 3.12 | Buy |
| 50-day SMA: | 3.99 | Sell |
| 200-day SMA: | 4.9 | Sell |
| 8-day EMA: | 3.19 | Sell |
| 20-day EMA: | 3.26 | Sell |
| 50-day EMA: | 3.83 | Sell |
| 200-day EMA: | 4.41 | Sell |
Black Diamond Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 42.36 | Sell |
| Chaikin Money Flow: | -241905 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.96 - 3.4) | Sell |
| Bollinger Bands (100): | (3.6 - 5.88) | Sell |
Black Diamond Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Black Diamond Therapeutics Stock
Is Black Diamond Therapeutics Stock a Buy?
- Black Diamond Therapeutics share price is 3.13 while BDTX 8-day simple moving average is 3.22, which is a Sell signal.
- The stock price of BDTX is 3.13 while Black Diamond Therapeutics 20-day SMA is 3.12, which makes it a Buy.
- Black Diamond Therapeutics 50-day simple moving average is 3.99 while BDTX share price is 3.13, making it a Sell technically.
- BDTX stock price is 3.13 and Black Diamond Therapeutics 200-day simple moving average is 4.90, creating a Sell signal.
BDTX Technical Analysis vs Fundamental Analysis
Sell
34
Black Diamond Therapeutics (BDTX)
is a Sell
Is Black Diamond Therapeutics a Buy or a Sell?
-
Black Diamond Therapeutics stock is rated a Sell
The current Black Diamond Therapeutics [BDTX] share price is $3.13. The Score for BDTX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Black Diamond Therapeutics Stock Info
Market Cap:
177.11M
Price in USD:
3.13
Share Volume:
332.62K
Black Diamond Therapeutics 52-Week Range
52-Week High:
7.66
52-Week Low:
1.95
Sell
34
Black Diamond Therapeutics (BDTX)
is a Sell
Black Diamond Therapeutics Share Price Forecast
-
What is the Black Diamond Therapeutics stock price today?
The Black Diamond Therapeutics stock price is 3.13 USD today. -
Will BDTX stock go up or go down?
Black Diamond Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Black Diamond Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Black Diamond Therapeutics is overvalued.
Is Black Diamond Therapeutics Stock a Buy?
- Black Diamond Therapeutics share price is 3.13 while BDTX 8-day exponential moving average is 3.19, which is a Sell signal.
- The stock price of BDTX is 3.13 while Black Diamond Therapeutics 20-day EMA is 3.26, which makes it a Sell.
- Black Diamond Therapeutics 50-day exponential moving average is 3.83 while BDTX share price is 3.13, making it a Sell technically.
- BDTX stock price is 3.13 and Black Diamond Therapeutics 200-day simple moving average is 4.41, creating a Sell signal.
Fundamental Analysis of Black Diamond Therapeutics
Is Black Diamond Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.02 per share.
Technical Analysis of Black Diamond Therapeutics
Should I short Black Diamond Therapeutics stock?
- BDTX Moving Average Covergence Divergence (MACD) indicator is -0.19, suggesting Black Diamond Therapeutics is a Sell
- Black Diamond Therapeutics Relative Strength Index (RSI) is 42.36, which suggest Black Diamond Therapeutics is oversold
- The Bollinger Bands (25) for Black Diamond Therapeutics is (2.96 - 3.4), which suggest Black Diamond Therapeutics is a Sell
- The Bollinger Bands (100) for Black Diamond Therapeutics is (3.6 - 5.88), which suggest Black Diamond Therapeutics is a Sell
* Black Diamond Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.